| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.26 |
3e-14 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-12 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.27 |
2e-12 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-12 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-12 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-11 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-11 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
8e-11 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
9e-11 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-10 |